Physician

Rishi Ramesh Patel, M.D.

According to 2025 Medicare claims, Rishi Patel, M.D. (NPI: 1487186094) practices hematology/oncology in the Decatur, AL market, with the plurality of this provider's patient population coming from Morgan, AL. This provider's primary affiliated billing organization is ONCOLOGY SPECIALTIES, P.C. (NPI: 1669425716; TIN: 630897317) and primary practice location at 35601-3354.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 780 traditional Medicare patients, billed 193,929 HCPCS/CPT codes, and received $3,680,932 in Medicare payments. The top billing code was 82728 (Ferritin (blood protein) level). Part D data shows 1,197 prescription claims across 196 beneficiaries totaling $2,700,877 in drug costs, led by Nubeqa (Darolutamide). Open Payments data shows 86 records totaling $4,481. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $2,695 to $2,700,877. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.7M2023 Medicare payment: $914,808 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,680,932 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
202341059,081$914,808
2024780193,929$3,680,932

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.4M$2.7M2017 Drug cost: $2,695 (USD; Tot_Drug_Cst)2018 Drug cost: $29,241 (USD; Tot_Drug_Cst)2019 Drug cost: $58,105 (USD; Tot_Drug_Cst)2020 Drug cost: $40,774 (USD; Tot_Drug_Cst)2021 Drug cost: $3,968 (USD; Tot_Drug_Cst)2022 Drug cost: $3,555 (USD; Tot_Drug_Cst)2023 Drug cost: $427,117 (USD; Tot_Drug_Cst)2024 Drug cost: $2,700,877 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171667$2,695
201851389$29,241
201964446$58,105
202059445$40,774
20211737$3,968
20221329$3,555
202390252$427,117
20241961,197$2,700,877

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
82728Ferritin (blood protein) level354726$13
80053Blood test, comprehensive group of blood chemicals6611,806$10
36415Insertion of needle into vein for collection of blood sample6651,909$9
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count6491,841$8
83540Iron level333590$6

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
NubeqaDarolutamide501,500$654,137
CalquenceAcalabrutinib Maleate23690$372,175
VonjoPacritinib Citrate12360$295,309
XtandiEnzalutamide20780$257,583
JakafiRuxolitinib Phosphate12351$192,049

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.86$4,481SOBI, INC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Rishi Ramesh Patel, M.D.?

Tedicare shows public-source Medicare data for Rishi Ramesh Patel, M.D. (NPI 1487186094), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rishi Ramesh Patel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Rishi Ramesh Patel, M.D.?

Rishi Ramesh Patel, M.D. is linked to ONCOLOGY SPECIALTIES, P.C. (billing NPI 1669425716) in the available physician profile data.

Does Rishi Ramesh Patel, M.D. have Open Payments data?

Rishi Ramesh Patel, M.D. has 86 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.